FDA's Top Drug Regulator Retiring

Richard Pazdur, a top federal drug regulator, has reportedly submitted his retirement papers, planning to leave the Food and Drug Administration by the end of this month. He was a central figure, leading the agencys primary drug oversight division, the Center for Drug Evaluation and Research, or CDER. Pazdur was appointed to lead CDER in mid-November, a move that placed him at the helm of a crucial division. He is known for founding the FDAs Oncology Center of Excellence and was described as a regulatory innovator by FDA Commissioner Marty Makary. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.